PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy
出版年份 2021 全文链接
标题
PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy
作者
关键词
-
出版物
npj Breast Cancer
Volume 7, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-05-05
DOI
10.1038/s41523-021-00246-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Strong impact of MammaPrint and BluePrint on treatment decisions in luminal early breast cancer: results of the WSG-PRIMe study
- (2019) R. Wuerstlein et al. BREAST CANCER RESEARCH AND TREATMENT
- Results of PONDx, a prospective multicenter study of the Oncotype DX® breast cancer assay: Real-life utilization and decision impact in French clinical practice
- (2019) Elsa Curtit et al. BREAST
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
- (2018) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prospective Evaluation of the Impact of the 21‐Gene Recurrence Score Assay on Adjuvant Treatment Decisions for Women with Node‐Positive Breast Cancer in Ontario, Canada
- (2018) Sofia Torres et al. ONCOLOGIST
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- First Prospective Multicenter Italian Study on the Impact of the 21‐Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer
- (2017) Maria Vittoria Dieci et al. ONCOLOGIST
- How to Identify and Manage Cognitive Dysfunction After Breast Cancer Treatment
- (2017) Marie Lange et al. Journal of Oncology Practice
- Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers
- (2017) Delphine Hequet et al. PLoS One
- Outcome disparities by age and 21-gene recurrence score® (RS) result in hormone receptor positive (HR+) breast cancer (BC)
- (2016) S. Shak et al. ANNALS OF ONCOLOGY
- The West German Study Group Breast Cancer Intrinsic Subtype study: a prospective multicenter decision impact study utilizing the Prosigna assay for adjuvant treatment decision-making in estrogen-receptor-positive, HER2-negative early-stage breast cancer
- (2016) R. Wuerstlein et al. CURRENT MEDICAL RESEARCH AND OPINION
- Pooled analysis of prospective European studies assessing the impact of using the 21-gene Recurrence Score assay on clinical decision making in women with oestrogen receptor–positive, human epidermal growth factor receptor 2–negative early-stage breast cancer
- (2016) Joan Albanell et al. EUROPEAN JOURNAL OF CANCER
- Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
- (2015) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2− early breast cancer
- (2014) R Exner et al. BRITISH JOURNAL OF CANCER
- US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
- (2014) Nadia Howlader et al. JNCI-Journal of the National Cancer Institute
- An International Ki67 Reproducibility Study
- (2013) Mei-Yin C. Polley et al. JNCI-Journal of the National Cancer Institute
- The impact of a genomic assay (Oncotype DX) on adjuvant treatment recommendations in early breast cancer
- (2013) Richard H de Boer et al. MEDICAL JOURNAL OF AUSTRALIA
- The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions
- (2013) Berit Maria Müller et al. PLoS One
- How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists
- (2012) Zsuzsanna Varga et al. PLoS One
- Evaluation of the costs and resource use associated with adjuvant chemotherapy for breast cancer in France
- (2012) Enora Laas et al. JOURNAL OF MEDICAL ECONOMICS
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort
- (2010) Foluso O. Ademuyiwa et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
- (2009) Kathy S Albain et al. LANCET ONCOLOGY
- Predictive Value of Tumor Ki-67 Expression in Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer
- (2008) Giuseppe Viale et al. JNCI-Journal of the National Cancer Institute
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now